Nepali Kunal, Lee Hsueh-Yun, Lai Mei-Jung, Ojha Ritu, Wu Tung-Yun, Wu Gu-Xian, Chen Mei-Chuan, Liou Jing-Ping
School of Pharmacy, College of Pharmacy, Taipei Medical University, Taiwan.
Center for Translational Medicine, Taipei Medical University, Taiwan.
Eur J Med Chem. 2017 Feb 15;127:115-127. doi: 10.1016/j.ejmech.2016.12.039. Epub 2016 Dec 21.
This study is focused on modification of the indole moiety and the N1-zinc binding domain of tubastatin A, and the effects of such changes on biological activity. Fourteen N-substituted indoles (5-18) were synthesized and structure-activity relationship studies indicated that the change of the tetrahydro-γ-carboline in tubastatin A led to substituted indoles (compounds 7, 11, and 15) which showed significant improvements of selective inhibition for HDAC6 over HDAC1 and HDAC2 in comparison to ACY1215, a compound undergoing clinical trials. In addition, attachment of different hydroxamic acid groups, the zinc binding motif at the N1 position, contributes to the antiproliferative activity in cancer cells. Several synthetic compounds exhibited potent growth inhibition in a broad spectrum of tumor cell lines, induced irreversible growth arrest capacities by suppressing colony formation ability and activated the apoptosis pathway. The data provide compelling evidence that our newly synthesized compounds with type B to D hydroxamic acid groups as the zinc binding motif at the N1 position are potent selective inhibitors of HDAC6 and could be investigated preclinically as potential anticancer drugs.
本研究聚焦于tubastatin A的吲哚部分和N1-锌结合结构域的修饰,以及此类变化对生物活性的影响。合成了14种N-取代吲哚(5 - 18),构效关系研究表明,tubastatin A中四氢-γ-咔啉的变化产生了取代吲哚(化合物7、11和15),与正在进行临床试验的化合物ACY1215相比,这些取代吲哚对HDAC6的选择性抑制作用相较于HDAC1和HDAC2有显著改善。此外,在N1位置连接不同的异羟肟酸基团(锌结合基序)有助于癌细胞的抗增殖活性。几种合成化合物在多种肿瘤细胞系中表现出强大的生长抑制作用,通过抑制集落形成能力诱导不可逆的生长停滞,并激活凋亡途径。数据提供了令人信服的证据,表明我们新合成的以B型至D型异羟肟酸基团作为N1位置锌结合基序的化合物是HDAC6的有效选择性抑制剂,可作为潜在抗癌药物进行临床前研究。